Genterapie SPK-8016 toon vroeë belofte vir erge hemofilie A

Genterapie SPK-8016 toon vroeë belofte vir erge hemofilie A

Hemofilie Nuus Vandag

Image

Please enable the javascript to submit this form

Ondersteun deur opvoedkundige toekennings van Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics en uniQure, Inc.

Noodsaaklike SSL